Publications by authors named "C Tombazzi"
GISTs are rare, with only around 5,000 cases diagnosed annually in the United States. However, these tumors are the most common mesenchymal neoplasm in the gastrointestinal (GI) tract. 5%-15% of GISTS arise in the colon and rectum.
View Article and Find Full Text PDFBaseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial.
Douglas J Robertson Jason A Dominitz Alexander Beed Kathy D Boardman Barbara J Del Curto Claudio Ruben Tombazzi
JAMA Netw Open
July 2023
Article Synopsis
- The CONFIRM trial aimed to compare the effectiveness of annual fecal immunochemical tests (FIT) versus colonoscopies in reducing colorectal cancer mortality, enrolling over 50,000 veterans between May 2012 and December 2017.
- The study analyzed participant demographics and examined reasons for those who chose not to participate, highlighting a mix of preferences for either colonoscopy or stool tests based on geographic and temporal factors.
- Among the 50,126 participants recruited, there was a diverse representation, and the study also noted that 11,109 eligible individuals opted out of participation for various reasons, with insights gathered via case report forms.